Siga Technologies, Inc.
Records under this name other than the patents Siga Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Back to Siga Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,498,470 | Antiviral Drugs for Treatment of Arenavirus Infection Formerly held In force · High confidence | In force | High confidence | |
| US 10,000,486 | Antiviral Drugs for Treatment of Arenavirus Infection Formerly held In force · High confidence | In force | High confidence | |
| US 7,687,641 | Chemicals, Compositions, and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Term ended Sep 27, 2024 · High confidence | Term ended | Term ended Sep 27, 2024 | High confidence |
| US 7,956,197 | Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Term ended Jun 18, 2024 · High confidence | Term ended | Term ended Jun 18, 2024 | High confidence |
| US 8,124,643 | Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Ended no later than Jun 18, 2024 · Medium confidence | Term ended | Ended no later than Jun 18, 2024 | Medium confidence |
| US 8,530,509 | Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Term ended Jun 18, 2024 · Medium confidence | Term ended | Term ended Jun 18, 2024 | Medium confidence |
| US 8,802,714 | Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Term ended Jun 18, 2024 · High confidence | Term ended | Term ended Jun 18, 2024 | High confidence |
| US 9,045,418 | Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases Term ended Term ended Jun 18, 2024 · High confidence | Term ended | Term ended Jun 18, 2024 | High confidence |
| US 9,067,873 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Formerly held Lapsed on the fee record Ended Jun 30, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2023 | From the USPTO record |
| US 8,754,082 | Antiviral drugs for treatment of Arenavirus infection Formerly held Lapsed on the fee record Ended Jun 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2022 | From the USPTO record |